 |
Medical Chief, Mood, Anxiety and Impulsivity Disorders Program, Douglas Institute
serge_dot_beaulieu_At_mcgill_dot_ca |
2007
Baptista T., Davila A., El Fakih Y., Uzcategui E., Rangel N. N., Olivares Y., Galeazzi T., Vargas D., Pena R., Marquina D., Villarroel V., Teneud L., Beaulieu S. (2007). Similar frequency of abnormal correlation between serum leptin levels and BMI before and after olanzapine treatment in schizophrenia, Int Clin Psychopharmacol, 22(4), 205-11.
Baptista T., Martinez M., Lacruz A., Arellano A., Mendoza S., Beaulieu S., Hernandez L., Contreras Q., Galeazzi T., Vargas D. (2007). Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia, Schizophr Res, 89(1-3), 350-2.
Baptista T., Rangel N., Fernandez V., Carrizo E., El Fakih Y., Uzcategui E., Galeazzi T., Gutierrez M. A., Servigna M., Davila A., Uzcategui M., Serrano A., Connell L., Beaulieu S., de Baptista E. A. (2007). Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial, Schizophr Res, 93(1-3), 99-108.
Baptista T., Sandia I., Lacruz A., Rangel N., de Mendoza S., Beaulieu S., Contreras Q., Galeazzi T., Vargas D. (2007). Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin, Int Clin Psychopharmacol, 22(2), 69-76.
Caron J., Tousignant M., Pedersen D., Fleury M., Cargo M., Daniel M., Kestin Y., Crocker A., Perreault M., Brunet A., Tremblay J., Turecki G., Beaulieu S. (2007). La création d’une nouvelle génération d’études épidémiologiques en santé mentale, Santé Ment Qué, 32(2), 27-36.
Parikh S. V., Velyvis V., Yatham L., Beaulieu S., Cervantes P., Macqueen G., Siotis I., Streiner D., Zaretsky A. (2007). Coping styles in prodromes of bipolar mania, Bipolar Disord, 9(6), 589-95.
Therrien F., Drapeau V., Lalonde J., Lupien S. J., Beaulieu S., Tremblay J., Richard D. (2007). Awakening cortisol response in lean, obese, and reduced obese individuals: effect of gender and fat distribution, Obesity, 15(2), 377-85.
